Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Basina

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|May 21, 2026
Poor Glycemic Status Is Associated With Diabetes Distress After Total Pancreatectomy With Islet AutotransplantationFaidat Adeola Ishola, Anne Eaton, Seung Kim, et al.
Diabetes Care|May 4, 2007
Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes: comparison of moderate fat versus carbohydrate reductionsTracey McLaughlin, Susan Carter, Cindy Lamendola, et al.
Diabetes Research and Clinical Practice|December 29, 2022
Disparities in adoption of new diabetic therapies with cardiovascular benefitsElena C Vasti, Marina Basina, Jamie Calma, et al.
Diabetes Care|September 25, 2019
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop SystemRayhan A Lal, Marina Basina, David M Maahs, et al.
The American Journal of Clinical Nutrition|October 7, 2006
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adultsTracey McLaughlin, Susan Carter, Cindy Lamendola, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETESByron J Hoogwerf, Kevin M Pantalone, Marina Basina, et al.
Diabetes Technology & Therapeutics|June 11, 2020
Fast-Acting Insulin Aspart Use with the MiniMed<sup>TM</sup> 670G SystemLiana Hsu, Bruce Buckingham, Marina Basina, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 25, 2025
Moving the Goalposts: Do Adults with Type 1 Diabetes Want Time in Tight Range (TITR)?Molly L Tanenbaum, Mabelle B Pasmooij, Rachel Tam, et al.
Human Reproduction (Oxford, England)|September 13, 2005
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndromeNicholas A Cataldo, Fahim Abbasi, Tracey L McLaughlin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2025
Moving the Goalposts: Do Adults With Type 1 Diabetes Want Time in Tight Range?Molly L Tanenbaum, Mabelle B Pasmooij, Rachel Tam, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|May 21, 2026
Poor Glycemic Status Is Associated With Diabetes Distress After Total Pancreatectomy With Islet AutotransplantationFaidat Adeola Ishola, Anne Eaton, Seung Kim, et al.
Diabetes Care|May 4, 2007
Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes: comparison of moderate fat versus carbohydrate reductionsTracey McLaughlin, Susan Carter, Cindy Lamendola, et al.
Diabetes Research and Clinical Practice|December 29, 2022
Disparities in adoption of new diabetic therapies with cardiovascular benefitsElena C Vasti, Marina Basina, Jamie Calma, et al.
Diabetes Care|September 25, 2019
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop SystemRayhan A Lal, Marina Basina, David M Maahs, et al.
The American Journal of Clinical Nutrition|October 7, 2006
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adultsTracey McLaughlin, Susan Carter, Cindy Lamendola, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETESByron J Hoogwerf, Kevin M Pantalone, Marina Basina, et al.
Diabetes Technology & Therapeutics|June 11, 2020
Fast-Acting Insulin Aspart Use with the MiniMed<sup>TM</sup> 670G SystemLiana Hsu, Bruce Buckingham, Marina Basina, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 25, 2025
Moving the Goalposts: Do Adults with Type 1 Diabetes Want Time in Tight Range (TITR)?Molly L Tanenbaum, Mabelle B Pasmooij, Rachel Tam, et al.
Human Reproduction (Oxford, England)|September 13, 2005
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndromeNicholas A Cataldo, Fahim Abbasi, Tracey L McLaughlin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2025
Moving the Goalposts: Do Adults With Type 1 Diabetes Want Time in Tight Range?Molly L Tanenbaum, Mabelle B Pasmooij, Rachel Tam, et al.
Pageof 6